News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
414,097 Results
Type
Article (17512)
Company Profile (72)
Press Release (396513)
Section
Business (126636)
Career Advice (838)
Deals (21902)
Drug Delivery (47)
Drug Development (43318)
Employer Resources (60)
FDA (11015)
Job Trends (8425)
News (205666)
Policy (17181)
Tag
Academia (1550)
Alliances (30853)
Alzheimer's disease (778)
Approvals (11008)
Artificial intelligence (111)
Bankruptcy (156)
Best Places to Work (7055)
Breast cancer (121)
Cancer (990)
Career advice (706)
CAR-T (78)
Cell therapy (216)
Clinical research (34979)
Collaboration (352)
Compensation (146)
COVID-19 (1312)
C-suite (97)
Data (980)
Diabetes (100)
Diagnostics (4055)
Earnings (53311)
Events (63723)
Executive appointments (339)
FDA (11551)
Funding (319)
Gene therapy (120)
GLP-1 (249)
Government (1978)
Healthcare (11767)
Infectious disease (1356)
Inflammatory bowel disease (67)
Interviews (103)
IPO (10491)
Job creations (1650)
Job search strategy (631)
Layoffs (162)
Legal (3756)
Lung cancer (139)
Lymphoma (79)
Manufacturing (106)
Medical device (10575)
Medtech (10577)
Mergers & acquisitions (11616)
Metabolic disorders (226)
Neuroscience (1003)
NextGen: Class of 2025 (3855)
Non-profit (2093)
Northern California (1222)
Obesity (103)
Opinion (93)
Patents (68)
People (35819)
Phase I (11012)
Phase II (15131)
Phase III (11824)
Pipeline (468)
Postmarket research (1289)
Preclinical (4608)
Press Release (68)
Radiopharmaceuticals (145)
Rare diseases (163)
Real estate (3143)
Regulatory (12308)
Research institute (1438)
Resumes & cover letters (140)
Southern California (1019)
Startups (2001)
United States (10640)
Vaccines (255)
Date
Today (79)
Last 7 days (364)
Last 30 days (1713)
Last 365 days (21545)
2025 (1762)
2024 (21894)
2023 (25328)
2022 (33727)
2021 (36030)
2020 (34843)
2019 (28522)
2018 (21513)
2017 (20097)
2016 (18846)
2015 (22949)
2014 (17395)
2013 (14145)
2012 (15428)
2011 (16163)
2010 (14951)
Location
Africa (366)
Arizona (142)
Asia (22180)
Australia (3285)
California (2713)
Canada (976)
China (166)
Colorado (123)
Connecticut (147)
Delaware (62)
Europe (50393)
Florida (416)
Georgia (80)
Illinois (234)
Indiana (143)
Japan (83)
Maryland (411)
Massachusetts (1998)
Michigan (132)
Minnesota (256)
New Jersey (840)
New York (793)
North Carolina (516)
Northern California (1222)
Ohio (100)
Pennsylvania (557)
South America (550)
Southern California (1019)
Texas (432)
Utah (81)
Washington State (273)
414,097 Results for "mts systems corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma
December 20, 2024
·
8 min read
Press Releases
PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA
October 22, 2024
·
3 min read
Drug Development
Mitsubishi Tanabe Pharma America Presents Final Results from the Global, Phase 3b MT-1186-A02 Post-marketing Study of RADICAVA® (edaravone) in ALS
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of final results from the global, multi-center, double-blind, Phase 3b MT-1186-A02 study of oral edaravone in amyotrophic lateral sclerosis (ALS).
June 17, 2024
·
7 min read
Press Releases
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
December 18, 2024
·
7 min read
Press Releases
Transforming Aesthetics: Dr. Maria Fedchuk’s Journey of Innovation at MTS US
August 5, 2024
·
5 min read
FDA
FDA Approves ColoSense™ – Geneoscopy’s Noninvasive Multi-target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced that the U.S. Food and Drug Administration (FDA) approved its noninvasive colorectal cancer screening test, ColoSense.
May 6, 2024
·
6 min read
Press Releases
Recursion updates L(earnings) call on August 8th to 8:30 am ET / 6:30 am MT
August 8, 2024
·
3 min read
Lone Star Bio
Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Molecular Templates, Inc. today announced that MTEM will present a poster, “First-in-human, dose escalation and expansion study of MT-6402 at the 2024 American Association for Cancer Research Annual Meeting taking place in San Diego, CA, and also announced monotherapy response activity in Head and Neck Cancer.
April 9, 2024
·
5 min read
Startups
GSK-backed Ouro Launches With $120M to ‘Reset’ the Immune System
Ouro is planning to leverage T cell engagers to deplete B cells and “reset” the immune system to treat immune-mediated diseases.
January 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™
January 6, 2025
·
4 min read
1 of 41,410
Next
